Track the Hartford Great Health Corp. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €100.1m. The latest transaction was reported on 4 April 2024 (Acquisition). Among the most active insiders: Lu Yuan. All data is free.
5
Insider Decl.
n/a
Thresholds
€244,415
4 ops.
Buy Volume
€560,818
1 ops.
Sell Volume
52Σ signal
Buys €244,415€560,818 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,606 of 28,899 companies
58.2
score / 100
Value
41
Quality
75
FCF yld0.9%
Earn yld1.1%
EV/EBITDA·
ROE·
Gross mgn96%
Net mgn78%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
600,000 shares@ US$0.02100.0% of flowCommonSEC:0001841429-24-000002:0
Canonical exit: 11 Jun 2024 (T+90)
5 of 5 declarations
About Hartford Great Health Corp.
Hartford Great Health Corp. is a company listed on the XNAS market, specializing in the healthcare sector. It focuses on improving health services and patient well-being.